Increase in incidence of diabetic retinopathy is a key factor responsible for the vitreous tamponades market growth. Vitreous tamponades or intraocular tamponades are used to avert the flow of intraocular fluid through retinal breaks, thereby helping maintain temporary retinal attachment and letting persistent chorioretinal adhesion appear post application of retinopexy. Rise in prevalence of vision disorders is another factor that is boosting vitreous tamponades industry size.
Leading vitreous tamponades industry manufacturers are exploring replacement of silicone oil tamponades with heavy silicone oil to eliminate the inefficiency of inferior retinal tamponades. This would also eradicate the risk associated with post-operative chronic hypotony. Companies operating in the global vitreous tamponades market are developing and manufacturing light and heavy retinal surgery tamponades to provide ophthalmic surgeons with innovative and efficient solutions.
Vitreous tamponades are used to maintain adhesion between retinal pigment epithelium (RPE) and retina post cryopexy or retinopexy.
Vitreous tamponades are available in the form of liquids and gases. Intraocular gas tamponades, such as perfluoropropane (C3F8) and sulfur hexafluoride (SF6), are non-toxic, odorless, colorless, and heaviker than air.
They retain their tamponade effect due to their higher surface tension. Liquids such as c (PFCL) flatten detached retina and displace subretinal fluid. Moreover, PFCL’s transparency makes it easy to use during intraoperative photocoagulation.
Other liquids such as silicone oil and heavy silicone oil are used to avoid formation of air/gas bubbles during retinal detachment caused by proliferative diabetic retinopathy and giant retinal tears.
Advantages of vitreous tamponades include permanent protection to ocular tissues that surround the retina. Tamponading is advisable to re-attach the retina.
However, non-biodegradability of SiO implants is prompting ophthalmologists to opt for endo-tamponades that can amalgamate therapeutic effectiveness and patient comfort levels. Polymeric hydrogels are preferred by eye specialists due to their biocompatibility and higher content of water.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
As per the IDF Diabetes Atlas, 537 million adults aged between 20 and 79 were living with diabetes in 2021. It further states that the number is expected to reach 643 million by the year 2030.
The IDF Diabetes Atlas also mentions that the year 2021 witnessed 6.7 million fatalities due to diabetes. The disease resulted in spending of US$ 966.0 Bn between 2006 and 2021.
Diabetes, if not controlled, can result in diabetic retinopathy. Research states that a person suffering from type 1, type 2, or gestational diabetes is likely to contract diabetic retinopathy.
The WHO states that 4.8% of the global population is affected by diabetic retinopathy. The percentage is anticipated to rise significantly during the forecast period.
Diabetic retinopathy, in the initial stage, causes walls of blood vessels in retina to bulge and weaken, which, in turn, form small pouches. They result in swelling of macula (called macular edema), thereby distorting the vision.
More than 50% of those suffering from diabetic retinopathy reportedly contract macular edema. If not treated in time, the advanced stage may symptomize blurring, blind spots, flashes, and difficulty in reading.
Treatment of diabetic retinopathy involves usage of silicone oil tamponade to ascertain clear media that would help ophthalmologists facilitate the surgery. Thus, growth in incidence of diabetic retinopathy is driving the global vitreous tamponades market demand.
Vision disorders include myopia (near-sightedness), astigmatism (distorted vision at distance), hyperopia (farsightedness), glaucoma, and presbyopia (generally occurring between 40 and 50 years of age).
As per the WHO, at least 2.2 billion people have distance or near vision impairment. It further states that 50% of vision impairment can be avoided if early detection followed by treatment is carried out. This is supported by the data that 7.7 million individuals suffer from glaucoma and 8 million from age-related macular degeneration.
Intraocular tamponades help provide a clear view with retinal stabilization in vitreomacular surgery and retinal detachment surgery.
Thus, need to cure vision disorders through timely administration of vitreous tamponades is bound to foster vitreous tamponades market in the next few years.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the vitreous tamponades market analysis, North America held the largest share of the global landscape in 2023. The region is projected to dominate the global industry during the forecast period.
According to the data released by the CDC, 9.6 million people in the U.S. were suffering from diabetic retinopathy in 2021. Of these, 1.84 million had vision-threatening diabetic retinopathy.
The vitreous tamponades market share of Europe has been increasing at a steady pace since the last few years owing to the rise in incidence of myopia in the region.
As per the International Agency for the Prevention of Blindness (IAPB), 47% of the European population in the age group of 25 to 29 is suffering from myopia, with the U.K, Italy, and France leading from the front.
Asia Pacific is likely to record steady market expansion in the near future due to the rise in retinal procedures in the region.
Companies operating in the worldwide vitreous tamponades market are incorporating new and innovative technologies to increase their client base. They are using heavy silicone oil and new vitreous gels along with potentially re-absorbing liquids that help cure retinal detachments.
Fluoron GmbH, Carl Zeiss Meditec AG, D.O.R.C Dutch Ophthalmic Research Center International B.V., Alchimia Srl, Bausch Health Companies, Inc., and Novartis AG are some of the companies covered in the vitreous tamponades market report.
These players have been highlighted based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 83.7 Mn |
| Market Forecast (Value) in 2034 | US$ 117.8 Mn |
| Growth Rate (CAGR) | 3.1% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 83.7 Mn in 2023
It is projected to grow at a CAGR of 3.1% from 2024 to 2034
Growth in prevalence of diabetic retinopathy and rise in incidence of vision disorders
The hospitals segment accounted for the largest share in 2023
North America was the dominant region in 2023
Fluoron GmbH, Carl Zeiss Meditec AG, D.O.R.C Dutch Ophthalmic Research Center International B.V., Alchimia Srl, Bausch Health Companies, Inc., and Novartis AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vitreous Tamponades Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vitreous Tamponades Market Analysis and Forecast, 2017 - 2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product Type/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Vitreous Tamponades Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017 - 2031
6.3.1. Gaseous Tamponades
6.3.2. Liquid Tamponades
6.3.2.1. Silicone Oil
6.3.2.2. Perfluorocarbon Liquids
6.4. Market Attractiveness Analysis, by Product Type
7. Global Vitreous Tamponades Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017 - 2031
7.3.1. Hospitals
7.3.2. Ophthalmology Clinics
7.4. Market Attractiveness Analysis, by End-user
8. Global Vitreous Tamponades Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017 - 2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Vitreous Tamponades Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product Type, 2017 - 2031
9.3.1. Gaseous Tamponades
9.3.2. Liquid Tamponades
9.3.2.1. Silicone Oil
9.3.2.2. Perfluorocarbon Liquids
9.4. Market Value Forecast, by End-user, 2017 - 2031
9.4.1. Hospitals
9.4.2. Ophthalmology Clinics
9.5. Market Value Forecast, by Country, 2017 - 2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product Type
9.6.2. By End-user
9.6.3. By Country
10. Europe Vitreous Tamponades Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017 - 2031
10.3.1. Gaseous Tamponades
10.3.2. Liquid Tamponades
10.3.2.1. Silicone Oil
10.3.2.2. Perfluorocarbon Liquids
10.4. Market Value Forecast, by End-user, 2017 - 2031
10.4.1. Hospitals
10.4.2. Ophthalmology Clinics
10.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Vitreous Tamponades Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017 - 2031
11.3.1. Gaseous Tamponades
11.3.2. Liquid Tamponades
11.3.2.1. Silicone Oil
11.3.2.2. Perfluorocarbon Liquids
11.4. Market Value Forecast, by End-user, 2017 - 2031
11.4.1. Hospitals
11.4.2. Ophthalmology Clinics
11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Vitreous Tamponades Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017 - 2031
12.3.1. Gaseous Tamponades
12.3.2. Liquid Tamponades
12.3.2.1. Silicone Oil
12.3.2.2. Perfluorocarbon Liquids
12.4. Market Value Forecast, by End-user, 2017 - 2031
12.4.1. Hospitals
12.4.2. Ophthalmology Clinics
12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Vitreous Tamponades Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017 - 2031
13.3.1. Gaseous Tamponades
13.3.2. Liquid Tamponades
13.3.2.1. Silicone Oil
13.3.2.2. Perfluorocarbon Liquids
13.4. Market Value Forecast, by End-user, 2017 - 2031
13.4.1. Hospitals
13.4.2. Ophthalmology Clinics
13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Fluoron GmbH
14.3.1.1. Company Overview
14.3.1.2. Product Type Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Carl Zeiss Meditec AG
14.3.2.1. Company Overview
14.3.2.2. Product Type Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. D.O.R.C Dutch Ophthalmic Research Center International B.V.
14.3.3.1. Company Overview
14.3.3.2. Product Type Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Alchimia Srl
14.3.4.1. Company Overview
14.3.4.2. Product Type Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Bausch Health Companies, Inc.
14.3.5.1. Company Overview
14.3.5.2. Product Type Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Novartis AG
14.3.6.1. Company Overview
14.3.6.2. Product Type Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
List of Tables
Table 01: Global Vitreous Tamponades Market Size (US$ Million) Forecast, by Product Type, 2017 - 2031
Table 02: Global Vitreous Tamponades Market Size (US$ Million) Forecast, by End-user, 2017 - 2031
Table 03: Global Vitreous Tamponades Market Size (US$ Million) Forecast, by Region, 2017 - 2031
Table 04: North America Vitreous Tamponades Market Size (US$ Million) Forecast, by Country, 2017 - 2031
Table 05: North America Vitreous Tamponades Market Size (US$ Million) Forecast, by Product Type, 2017 - 2031
Table 06: North America Vitreous Tamponades Market Size (US$ Million) Forecast, by End-user, 2017 - 2031
Table 07: Europe Vitreous Tamponades Market Size (US$ Million) Forecast, by Country/Sub-region, 2017 - 2031
Table 08: Europe Vitreous Tamponades Market Size (US$ Million) Forecast, by Product Type, 2017 - 2031
Table 09: Europe Vitreous Tamponades Market Size (US$ Million) Forecast, by End-user, 2017 - 2031
Table 10: Asia Pacific Vitreous Tamponades Market Size (US$ Million) Forecast, by Country/Sub-region, 2017 - 2031
Table 11: Asia Pacific Vitreous Tamponades Market Size (US$ Million) Forecast, by Product Type, 2017 - 2031
Table 12: Asia Pacific Vitreous Tamponades Market Size (US$ Million) Forecast, by End-user, 2017 - 2031
Table 13: Latin America Vitreous Tamponades Market Size (US$ Million) Forecast, by Country/Sub-region, 2017 - 2031
Table 14: Latin America Vitreous Tamponades Market Size (US$ Million) Forecast, by Product Type, 2017 - 2031
Table 15: Latin America Vitreous Tamponades Market Size (US$ Million) Forecast, by End-user, 2017 - 2031
Table 16: Middle East & Africa Vitreous Tamponades Market Size (US$ Million) Forecast, by Country/Sub-region, 2017 - 2031
Table 17: Middle East & Africa Vitreous Tamponades Market Size (US$ Million) Forecast, by Product Type, 2017 - 2031
Table 18: Middle East & Africa Vitreous Tamponades Market Size (US$ Million) Forecast, by End-user, 2017 - 2031
List of Figures
Figure 01: Global Vitreous Tamponades Market Size (US$ Million) and Distribution (%), by Region, 2022 - 2031
Figure 02: Global Vitreous Tamponades Market Revenue (US$ Million), by Product Type, 2022
Figure 03: Global Vitreous Tamponades Market Value Share, by Product Type, 2022
Figure 04: Global Vitreous Tamponades Market Revenue (US$ Million), by End-user, 2022
Figure 05: Global Vitreous Tamponades Market Value Share, by End-user, 2022
Figure 06: Global Vitreous Tamponades Market Value Share, by Region, 2022
Figure 07: Global Vitreous Tamponades Market Value (US$ Million) Forecast, 2023 - 2031
Figure 08: Global Vitreous Tamponades Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 09: Global Vitreous Tamponades Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 10: Global Vitreous Tamponades Market Value Share Analysis, by End-user, 2022 - 2031
Figure 11: Global Vitreous Tamponades Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 12: Global Vitreous Tamponades Market Value Share Analysis, by Region, 2022 - 2031
Figure 13: Global Vitreous Tamponades Market Attractiveness Analysis, by Region, 2023 - 2031
Figure 14: North America Vitreous Tamponades Market Value (US$ Million) Forecast and Y-o-Y Growth (%), 2017 - 2031
Figure 15: North America Vitreous Tamponades Market Attractiveness Analysis, by Country, 2023 - 2031
Figure 16: North America Vitreous Tamponades Market Value Share Analysis, by Country, 2022 - 2031
Figure 17: North America Vitreous Tamponades Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 18: North America Vitreous Tamponades Market Value Share Analysis, by End-user, 2022 - 2031
Figure 19: North America Vitreous Tamponades Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 20: North America Vitreous Tamponades Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 21: Europe Vitreous Tamponades Market Value (US$ Million) Forecast and Y-o-Y Growth (%), 2017 - 2031
Figure 22: Europe Vitreous Tamponades Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 23: Europe Vitreous Tamponades Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 24: Europe Vitreous Tamponades Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 25: Europe Vitreous Tamponades Market Value Share Analysis, by End-user, 2022 - 2031
Figure 26: Europe Vitreous Tamponades Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 27: Europe Vitreous Tamponades Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 28: Asia Pacific Vitreous Tamponades Market Value (US$ Million) Forecast and Y-o-Y Growth (%), 2017 - 2031
Figure 29: Asia Pacific Vitreous Tamponades Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 30: Asia Pacific Vitreous Tamponades Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 31: Asia Pacific Vitreous Tamponades Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 32: Asia Pacific Vitreous Tamponades Market Value Share Analysis, by End-user, 2022 - 2031
Figure 33: Asia Pacific Vitreous Tamponades Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 34: Asia Pacific Vitreous Tamponades Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 35: Latin America Vitreous Tamponades Market Value (US$ Million) Forecast and Y-o-Y Growth (%), 2017 - 2031
Figure 36: Latin America Vitreous Tamponades Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 37: Latin America Vitreous Tamponades Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 38: Latin America Vitreous Tamponades Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 39: Latin America Vitreous Tamponades Market Value Share Analysis, by End-user, 2022 - 2031
Figure 40: Latin America Vitreous Tamponades Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 41: Latin America Vitreous Tamponades Market Attractiveness Analysis, by End-user, 2023 - 2031
Figure 42: Middle East & Africa Vitreous Tamponades Market Size (US$ Million) Forecast and Y-o-Y Growth (%), 2017 - 2031
Figure 43: Middle East & Africa Vitreous Tamponades Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031
Figure 44: Middle East & Africa Vitreous Tamponades Market Value Share Analysis, by Country/Sub-region, 2022 - 2031
Figure 45: Middle East & Africa Vitreous Tamponades Market Value Share Analysis, by Product Type, 2022 - 2031
Figure 46: Middle East & Africa Vitreous Tamponades Market Value Share Analysis, by End-user, 2022 - 2031
Figure 47: Middle East & Africa Vitreous Tamponades Market Attractiveness Analysis, by Product Type, 2023 - 2031
Figure 48: Middle East & Africa Vitreous Tamponades Market Attractiveness Analysis, by End-user, 2023 - 2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Vitreous Tamponades Market
*86 figures and 60 tables includes